Pharma

Advances in veterinary medicine focus on the Mhyosphere PCV ID vaccine, developed to address significant health challenges in pig populations. Recent evaluations spotlight a...

Takeda has released promising interim data from its Phase 1b clinical study, showcasing the sustained efficacy of mezagitamab in primary IgA nephropathy treatment. This...

The escalating expenditure on cancer treatments, particularly checkpoint inhibitors, has drawn the attention of healthcare policymakers and providers in the United States. As these...

At the American Heart Association's 2025 Scientific Sessions, revolutionary findings emerged about olezarsen's potential in treating severe hypertriglyceridemia (sHTG). These groundbreaking results, presented as...

British Columbia has introduced a groundbreaking cancer control policy aiming to reimburse multi-gene panel testing and pembrolizumab therapy for patients dealing with metastatic melanoma....

Generalized myasthenia gravis presents significant challenges to individuals affected due to its fluctuating muscle weakness. The MycarinG study has emerged as a pivotal investigation...

Collegium Pharmaceutical is riding a wave of robust growth, closing the third quarter of 2025 with exceptional financial results. The company revealed a striking...

A recent breakthrough by Camurus has revealed positive data from their Phase 1b study on CAM2056, a monthly semaglutide formulation. Unveiling a significant stride...

Regeneron Pharmaceuticals, Inc. and Sanofi have announced impressive outcomes from their recent Phase 3 trial, showcasing the effectiveness of Dupixent in alleviating allergic fungal...

Takeda Pharmaceutical Company has set a new benchmark in dengue prevention with its QDENGA® dengue vaccine, which has demonstrated an impressive 7-year protective efficacy...

Sumitomo Pharma America, Inc. (SMPA) presents its latest research breakthroughs in the realms of acute myeloid leukemia (AML) and myelofibrosis (MF) at the 67th...

Advanced esophageal squamous cell carcinoma (ESCC) presents a daunting challenge in oncology with its poor prognosis and limited treatment options. Recent advances in immunotherapy,...

In the evolving landscape of lung cancer research, multifocal ground-glass nodules (GGNs) are emerging as a crucial clinical entity. These nodules present complex challenges...

The pursuit of optimal cancer treatment balancing effectiveness with manageable side effects continues to challenge healthcare professionals and researchers. Regorafenib, utilized in metastatic colorectal...

Dupixent® (dupilumab), a therapeutic innovation by Regeneron Pharmaceuticals, has been lauded for its unparalleled contributions to treating allergic and atopic conditions. Acknowledged by the...